Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients
- 19 June 2000
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 287 (3) , 187-190
- https://doi.org/10.1016/s0304-3940(00)01178-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's diseaseNeuroscience Letters, 1999
- Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSFNeurology, 1999
- Discriminant power of combined cerebrospinal fluid τ protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's diseaseBrain Research, 1999
- Hierarchical Phosphorylation of Recombinant Tau by the Paired‐Helical Filament‐Associated Protein Kinase Is Dependent on Cyclic AMP‐Dependent Protein KinaseJournal of Neurochemistry, 1999
- Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease markerJournal of Clinical Laboratory Analysis, 1998
- Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in JapanAnnals of Neurology, 1998
- Cerebrospinal Fluid Tau Levels in Neurodegenerative Diseases with Distinct Tau-Related PathologyBiochemical and Biophysical Research Communications, 1997
- tau protein in cerebrospinal fluidMolecular and Chemical Neuropathology, 1995
- The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptorNature, 1987
- “Mini-mental state”Journal of Psychiatric Research, 1975